BFC Planning’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13.4M Buy
465,189
+465,154
+1,329,011% +$11.4M 0.53% 32
2026
Q2
$751 Hold
35
– – ﹤0.01% 3203
2026
Q1
$486 Buy
+35
New +$558 ﹤0.01% 2860

Other funds holding ADPT

BFC Planning's ADPT Position: Q3 2026 in Review

BFC Planning increased its Adaptive Biotechnologies (ADPT) stake by 1,329,011% in Q3 2026, buying an estimated $11.4M and bringing the position to 465,189 shares worth $13.4M. The position accounts for 0.53% of the portfolio, ranked #32.

BFC Planning first reported a position in ADPT in Q1 2026 and has held it in 3 quarters since. 244 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • BFC Planning held 465,189 shares of Adaptive Biotechnologies worth $13.4M as of Q3 2026.
  • BFC Planning bought 465,154 Adaptive Biotechnologies shares in Q3 2026, an estimated $11.4M.
  • Adaptive Biotechnologies made up 0.53% of BFC Planning's portfolio in Q3 2026, its #32 holding.
  • BFC Planning first reported a position in Adaptive Biotechnologies in Q1 2026 and has held it in 3 quarters since.
  • 244 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.